US FDA Officials Provide Primer On 'Real-World' Data
Executive Summary
In a journal article, Center for Drug Evaluation and Research Director Janet Woodcock and colleagues describe the sources of real-word evidence and study designs that can be used to generate such evidence.
You may also be interested in...
CDER Safety Overhaul Planned As Review Process Modernization Continues
US FDA's Woodcock tells the Pink Sheet that goals include eliminating duplication through creation of one safety review process.
Roche’s External Control Arms Show What Real-World Evidence Can Look Like In Practice
With Flatiron, Roche is at the forefront of the emerging field of RWE. Roche Pharma President O’Day described how the company is using such data in the real world of regulation and reimbursement.
Real-World Data Could Get Boost From Trial Replication Project
Effort to replicate clinical trial results with real-world data could eventually allow for increased use in drug development.